BTI
CRSP icon

Blue Trust Inc’s CRISPR Therapeutics CRSP Stock Holding History

Blue Trust Inc’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190 Buy
+4
New +$211 ﹤0.01% 2413
2025
Q4 		– Sell
-6
Closed -$389 – 2567
2025
Q3 		$389 Hold
6
– – ﹤0.01% 2453
2025
Q2 		$292 Hold
6
– – ﹤0.01% 2361
2025
Q1 		$204 Hold
6
– – ﹤0.01% 2419
2024
Q4 		$236 Sell
6
-3,838
-100% -$181K ﹤0.01% 2378
2024
Q3 		$208K Buy
3,844
+2,358
+159% +$120K ﹤0.01% 836
2024
Q2 		$101K Buy
1,486
+1,437
+2,933% +$83.1K ﹤0.01% 971
2024
Q1 		$3.34K Sell
49
-455
-90% -$32.6K ﹤0.01% 1713
2023
Q4 		$23K Buy
+504
New +$27.9K ﹤0.01% 1219
2023
Q3 		– Sell
-3
Closed – – 2081
2023
Q2 		$0 Sell
3
-23
-88% -$1.3K ﹤0.01% 2101
2023
Q1 		$1K Sell
26
-85
-77% -$4.13K ﹤0.01% 2130
2022
Q4 		$7K Buy
111
+98
+754% +$5.2K ﹤0.01% 1622
2022
Q3 		$1K Buy
+13
New +$942 ﹤0.01% 1902

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return